Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 813

DECLARATION re 811 MOTION in Limine to Preclude Amgen Inc. from Asserting that the Generation of Tryptic Fragments and Determination of the Amino Acid Sequence of EPO was Novel and Non-Obvious (by Krista M. Rycroft) by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2# 3 Exhibit 3# 4 Exhibit 4# 5 Exhibit 5# 6 Exhibit 6# 7 Exhibit 7)(Brooks, Kregg)

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Doc. 813 Att. 2 Case 1:05-cv-12237-WGY Document 813-3 Filed 08/13/2007 Page 1 of 6 Exhibit 2 Dockets.Justia.com Case 1:05-cv-12237-WGY Document 813-3 Filed 08/13/2007 Page 2 of 6 Case 1:05-cv-12237-WGY Document 813-3 Filed 08/13/2007 Page 3 of 6 Case 1:05-cv-12237-WGY Document 813-3 Filed 08/13/2007 Page 4 of 6 Case 1:05-cv-12237-WGY Document 813-3 Filed 08/13/2007 Page 5 of 6 Case 1:05-cv-12237-WGY Document 813-3 Filed 08/13/2007 Page 6 of 6

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?